Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Covington
Boehringer Ingelheim
Accenture
Teva
QuintilesIMS
Chinese Patent Office
Federal Trade Commission
AstraZeneca

Generated: May 21, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ambrisentan

« Back to Dashboard

ambrisentan

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Gilead LETAIRIS ambrisentan TABLET;ORAL 022081 NDA Gilead Sciences, Inc N 61958-0801-1
Gilead LETAIRIS ambrisentan TABLET;ORAL 022081 NDA Gilead Sciences, Inc N 61958-0801-2
Gilead LETAIRIS ambrisentan TABLET;ORAL 022081 NDA Gilead Sciences, Inc N 61958-0801-3
Gilead LETAIRIS ambrisentan TABLET;ORAL 022081 NDA Gilead Sciences, Inc N 61958-0801-4
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
UBS
Queensland Health
Covington
Chubb
Accenture
Daiichi Sankyo
Argus Health